HIVE Digital Technologies Ltd. builds and operates data centers powered primarily by renewable energy across Canada, Sweden, and Paraguay. The company began as one of the first publicly listed Bitcoin miners to emphasize green energy, and it continues to generate revenue from digital currency mining. In recent years, HIVE has accelerated a strategic pivot toward high-performance computing (HPC) and AI cloud services through its BUZZ HPC subsidiary, which rents out graphics processing units to enterprise customers. Investors follow the stock both for its exposure to Bitcoin and for its efforts to build a steadier, contract-based revenue stream in the AI infrastructure market. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, HIVE shares declined approximately 35%, falling from a closing level near $2.75 in early October to roughly $1.78 in early November. The move was not isolated; it occurred alongside a retreat in Bitcoin prices and a broad risk-off tilt across the sector.
The quarterly picture is similar. Measured from early August, when shares traded near $2.76, the stock is down about 35% as well. HIVE rallied into mid-September, reaching levels around $3.40 after announcing its largest AI contract to date, before giving back those gains as crypto prices pulled back and investor sentiment toward the group weakened.
Several factors combined to pressure HIVE over the past month. First, Bitcoin retreated from its record highs, dragging down the valuation of miners whose revenue is tied to digital asset prices. Weaker Bitcoin and softer mining economics reduced the appeal of the mining side of the business.
Second, sentiment toward crypto-mining and AI-infrastructure names deteriorated more broadly. Treasury yields near multi-decade highs and a risk-off environment weighed on capital-intensive growth stories across the sector.
Third, sell-side analysts trimmed price targets on HIVE, with firms such as Keefe, Bruyette & Woods lowering their outlooks. Combined with a large fiscal first-quarter GAAP net loss — driven in part by a non-cash VAT-related charge tied to its Swedish operations — the revisions added to selling pressure.
Finally, from a technical standpoint, the stock broke below its 50-day and 200-day moving averages, which often triggers further momentum-based selling.
Over the broader quarter, HIVE's story has been defined by its continued transition toward AI and HPC. The company signed a five-year, roughly $350 million GPU cloud agreement in August, its largest AI contract to date, and announced that BUZZ HPC had accumulated more than $600 million in GPU cloud contracts. Those announcements helped push shares higher into mid-September.
However, the rally faded as the crypto market cooled and as investors reassessed execution risk, financing needs, and profitability. The fiscal first-quarter report showed strong revenue growth but a substantial GAAP loss, while heavy capital requirements for the AI buildout remained in focus. The net result was a quarter that began and ended near similar levels, with most of the decline concentrated in the final month.
Looking ahead, the direction of Bitcoin prices remains the most immediate swing factor for HIVE's mining revenue and overall sentiment. Investors should also monitor the company's quarterly earnings and updates on the deployment of its NVIDIA GPU clusters, progress toward its GPU cloud revenue targets, and any changes in analyst price targets or financing activity. Broader macroeconomic conditions, including interest rates and risk appetite, will continue to influence how the market values capital-intensive crypto and AI-infrastructure businesses. From what I see, this is important because execution on the AI side could provide a buffer if Bitcoin volatility persists.
One tool I find useful for this kind of analysis is Tickeron’s AI Trading Bots. It lets me review how automated strategies are positioning across the market and offers a useful starting point for data-driven signals on names like HIVE.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for HIVE turned positive on November 06, 2026. Looking at past instances where HIVE's MACD turned positive, the stock continued to rise in 33 of 37 cases over the following month. The odds of a continued upward trend are 89%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HIVE's RSI Oscillator exited the oversold zone, 36 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +6.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in 211 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
HIVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In 67 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
HIVE moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HIVE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
The 50-day moving average for HIVE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HIVE entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.972) is normal, around the industry mean (3.132). P/E Ratio (9.174) is within average values for comparable stocks, (6.756). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.982) among similar stocks. P/S Ratio (2.169) is also within normal values, averaging (16.899).
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. HIVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers